Defensive Driving: Directing HIV-1 Vaccine-Induced Humoral Immunity to the Mucosa with Chemokine Adjuvants
A myriad of pathogens gain access to the host via the mucosal route; thus, vaccinations that protect against mucosal pathogens are critical. Pathogens such as HIV, HSV, and influenza enter the host at mucosal sites such as the intestinal, urogenital, and respiratory tracts. All currently licensed va...
Saved in:
Main Authors: | Ebony N. Gary, Michele A. Kutzler |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2018/3734207 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Study of humoral immunity in animals immunized with emulsion FMD vaccines
by: S. R. Kremenchugskaya, et al.
Published: (2018-04-01) -
Studies on humoral immunity in dogs after use of rabies inactivated vaccines formulated with Montanide ISA 70 VG and GEL 01 adjuvants
by: A. N. Balashov, et al.
Published: (2020-03-01) -
DDO-adjuvanted influenza A virus nucleoprotein mRNA vaccine induces robust humoral and cellular type 1 immune responses and protects mice from challenge
by: Victoria Gnazzo, et al.
Published: (2025-02-01) -
Humoral Immune Response to Keyhole Limpet Haemocyanin, the Protein Carrier in Cancer Vaccines
by: A. Kantele, et al.
Published: (2011-01-01) -
Editorial: Tuberculosis and humoral immunity
by: Taru S. Dutt, et al.
Published: (2025-02-01)